Bone Loss Active Not Recruiting Phase 0 Trials for Denosumab (DB06643)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03292146Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot StudyTreatment